Genomic deoxyribonucleic acid (gDNA) (gDNA)

Genomic deoxyribonucleic acid (gDNA) is the complete set of genetic material within an organism, primarily organized into chromosomes within the cell nucleus. It serves as the fundamental blueprint for life, encoding all biological information necessary for cellular function, growth, and reproduction through the processes of transcription and replication. In pharmacology, genomic DNA is a major therapeutic target, particularly in the treatment of cancer, where drugs are designed to disrupt its integrity or function in rapidly dividing cells. These agents, including alkylating agents, intercalators, and platinum-based compounds, interact with specific sites (often referred to as "d sites" or deoxyribonucleic acid sites, such as d(GpG) or d(ApG) dinucleotides) to form covalent adducts, cross-links, or intercalated complexes. These interactions lead to DNA damage, inhibition of DNA synthesis, and the induction of apoptosis. While highly effective, targeting genomic DNA presents significant safety challenges, including mutagenicity, which can lead to secondary malignancies, and systemic toxicities such as myelosuppression and organ damage.

Other names

Genomic DNAChromosomal DNANuclear DNADeoxyribonucleic acid

Drugs targeting genomic DNA typically act through covalent alkylation of nucleotide bases (e.g., N7 of guanine), intercalation between base pairs, induction of single- or double-strand breaks, or the formation of inter-strand and intra-strand cross-links. These modifications disrupt DNA replication and transcription, leading to cell cycle arrest and the induction of apoptosis in rapidly dividing cells.